Telegram Web Link
Clinical Notes
๐Ÿ›‘ู‚ุฏ ูŠุฎูŠู„ ู„ูƒ ุงู† ุงู†ุฎูุงุถ ุงู„ุตูˆุฏูŠูˆู… hyponatraemia ูˆ ุงู„ุจูˆุชุงุณูŠูˆู… hypokalemia ูŠูƒูˆู† ุฃูƒุซุฑ ููŠ ู…ุณุชุฎุฏู…ูŠ ู…ุฏุฑุงุช loop diuretic( ู…ุซู„ ู„ุงุฒูƒุณ ) ู…ู‚ุงุฑู†ุฉ ุจู…ุณุชุฎู…ุฏูŠ ู…ุฏุฑุงุช Thiazide diuretics( ู…ุซู„ Hydrochlorothiazide )โŒโŒ โœ…ูˆู„ูƒู† ููŠ ุงู„ุญู‚ูŠู‚ู‡ ุจูŠูƒูˆู† ุงูƒุซุฑ ููŠ ุงู„ู…ุฑุถู‰ ุงู„ุฐูŠู† ูŠุณุชุฎุฏู…ูˆุง ู…ุฏุฑุงุชโ€ฆ
๐Ÿ›‘Overall, hypokalemia is more frequent with thiazide diuretics than with loop diuretics, despite having a less potent natriuretic effect
โœ… One potential explanation is the differential effect on calcium excretion. Whereas thiazide diuretics decrease calcium excretion  loop diuretics lead to a significant increase in calcium excretion The higher luminal calcium concentration in the distal nephron produced by loop diuretics reduces the lumen-negative driving force for potassium excretion , thereby blunting their kaliuretic effect of loop diuretics.

#UpTodate2023
#salah
๐Ÿ›‘Management of LDL-C to reduce cardiovascular risk in nondialysis CKD patients


๐Ÿ›‘Statin for secondary prevention
if A patient has established atherosclerotic CVD (prior history of coronary, cerebrovascular, or peripheral arterial disease)


๐Ÿ›‘Statin for primary prevention 


โ›”๏ธOption A

โœ…All patients with GFR <60 mL/min

โœ…Patients with CKD and GFR โ‰ฅ60 mL/min and age โ‰ฅ50 years

or

โœ…Patients with CKD and GFR โ‰ฅ60mL/min and other CVD risk factors (eg, diabetes, hypertension, smoking, low HDL-C, high Lp(a), etc

โ›”๏ธOption B*:

โœ…Statin if predicted 10-year absolute risk of having a major CVD event is 7.5 to 10% or higher

โœ…Statin might be offered if risk is between 5 and 7.5%

โœ…No statin if risk is below 5%



#Note
โœ…Option A and Option B reflect differing opinions among UpToDate authors and editors about criteria for initiating statin therapy in patients with nondialysis CKD

#UpTodate2023
#salah
ูู‚ุท ููŠ ุงู„ู…ูˆุงู‚ุน ูˆุงู„ู…ุตุงุฏุฑ ุงู„ุทุจูŠุฉ ุงู„ุบุฑุจ ูŠุชูƒู„ู…ูˆู† ุนู† ุงู„ู…ุจุงุฏุฆ ูˆุงู„ุฃุฎู„ุงู‚ ููŠ ุงู„ุชุนุงู…ู„ ู…ุน ุงู„ู…ุฑูŠุถ ุŒููŠู…ุง ูŠุบู„ู‚ูˆู† ุงุฐุงู†ู‡ู… ูˆุนูŠูˆู†ู‡ู… ุนู† ุงู„ุงุญุชู„ุงู„ ูˆู‡ูˆ ูŠู†ูƒู„ ูˆูŠุฎุชุทู ุฌุซุซ ุงู„ุดู‡ุฏุงุก ูˆูŠู‚ุชุญู… ุงู„ู…ุณุชุดููŠุงุช ูˆุงู„ู…ุฑุงูู‚ ุงู„ุตุญูŠุฉ ุŒ ูˆุชุฌุฏ ุฃูŠุถุง ุงู„ู…ุชุตู‡ูŠู†ูŠู† ุงู„ุนุฑุจ ูŠู„ู‚ูˆู† ุจุงู„ู„ูˆู… ุนู„ู‰ ุญู…ุงุณ ุนู„ู‰ ู…ุงูุนู„ุชู‡ ููŠ ุงู„ุณุงุจุน ู…ู† ุฃูƒุชูˆุจุฑ ุงู„ู…ุฌูŠุฏ
Clinical Notes
https://forms.gle/U3jKXMkA5WWoaNyi8
ู„ุชุฐูƒูŠุฑ
ุบุฏุง ุงู„ู…ูˆุนุฏ ุงู„ุณุงุนู‡ ูฃ ุนุตุฑุง
ุนุจุฑ ุชุทุจูŠู‚ ุงู„ุฒูˆู… ุงูˆ ุงู„ุญุถูˆุฑ
https://ust.edu.ye/rcr2023/
#remember
๐Ÿ›‘Principles use of vassopressors

โœ…  Vasopressors are indicated for an MAP <60 mmHg, or a decrease of systolic blood pressure that exceeds 30 mmHg from baseline, when either condition results in end-organ dysfunction due to hypoperfusion.

#UpTodate2023
ุฑุงุจุท ุญุถูˆุฑ ูŠูˆู… ุงู„ุฃุญุฏ
ููŠ ู…ุคุชู…ุฑ ุฃุฎู„ุงู‚ูŠุงุช ุงู„ุจุญุซ ุงู„ุนู„ู…ูŠ


Day2: 10-12-2023
https://tinyurl.com/yc87zz72
ููŠ ุญุงู„ู‡ ุงู„
ischemic stroke
ู…ุง ู†ูุถู„ ุฅุณุชุฎุฏุงู… ู…ุถุงุฏุงุช ุงู„ุชุฌู„ุท ู…ุซู„ warfarin, heparin, DOACs
ุฎู„ุงู„ ุงูˆู„ ุงุณุจูˆุนูŠู† ูˆุงู„ุณุจุจ ุน ุดุงู† ู…ุง ูŠุตูŠุฑ
haemorrhagic transformation
ููŠ ุญุงู„ู‡ ุงู† ุงู„ู…ุฑูŠุถ ู…ุฑูƒุจ
prosthetic heart valves
ูˆู‡ุงุฐุง ูŠูƒูˆู† ุนู†ุฏู‡
High risk of stroke
ู„ูƒู† ุนู†ุฏู‡
significant ischaemic stroke and are at risk of haemorrhagic transformation
ุชู‚ุฒู„ ุงู„ NICE ุงู„ุจุฑูŠุทุงู†ูŠู‡ ุงู†ู‡ ู†ุนู…ู„
Hold for anticoagulation for 1 week and start aspirin 300mg
ุงู…ุง ุงุฐุง ูƒุงู† ุนู†ุฏู‡
non-valvular AF or paroxysmal AF
ู†ูˆู‚ู ุงู„ DOAC ู„ู…ุฏุฉ 14 ูŠูˆู…

ุจูŠู†ู…ุง ุงู„ู…ุฑูŠุถ ุงู„ูŠ ุนู†ุฏู‡
VTE (DVT, PE)
ู‡ู†ุง ู†ุญุฏุฏ ุบ ุญุณุจ ุงู„ู…ุฑูŠุถ ู‡ู„ ู‡ูˆ ุญุงุฏ ุงูˆ ู„ู‰ ู‡ู„ ู†ุณุชุฎุฏู…
Nonpharmacolgy or anticoagulant

ุทูŠุจ ุจุงู„ู†ุณุจู‡ ุงุฐุง ู†ุฑูŠุฏ ู†ุนู…ู„
VTE Prophylaxis in patients with stroke ?
ููŠ ุงู„ู…ู†ุดูˆุฑ ุงู„ู‚ุงุฏู… ุงู† ุดุงุก ุงู„ู„ู‡
#massoud
#remember
๐Ÿ›‘ Betamethasone and dexamethasone have low mineralocorticoid activity compared with other corticosteroids; therefore, hypertension is not a contraindication to therapy๐Ÿ‘

#UpTodate2023
Clinical Notes
#remember ๐Ÿ›‘ Betamethasone and dexamethasone have low mineralocorticoid activity compared with other corticosteroids; therefore, hypertension is not a contraindication to therapy๐Ÿ‘ #UpTodate2023
#remember
ู†ุญู† ู†ุฏุฑูƒ ุฃู‡ู…ูŠุฉ ุฏูˆุงุก betamethasone ุงูˆ dexamethasone ู„ู„ุฌู†ูŠู† ุงู„ุฐูŠ ุจูŠูƒูˆู† ู…ุนุฑุถ ู„ู„ูˆู„ุงุฏุฉ ุงู„ู…ุจูƒุฑู‡ patients at risk for preterm birth ุนุดุงู† ู†ู‚ู„ู„ severity of respiratory distress syndrome (RDS)
ู„ูƒู† ุงุฐุง ูƒุงู†ุช ุงู„ุงู… ุงู„ุญุงู…ู„ ู…ุตุงุจุฉ ุจุงุฑุชูุงุน ุถุบุท ุงู„ุฏู… ุงู„ุฏู… ู„ุฃูŠ ุณุจุจ ุชุณู…ู… ุญู…ู„ูŠ ุงูˆ ุบูŠุฑู‡ ู‡ู„ ุชุนุชุจุฑ ู‡ุฐู‡ ุงู„ุงุฏูˆูŠุฉ ู…ู…ู†ูˆุนู‡ ุŸ

ุงู„ุงุฌุงุจู‡ ู„ุง
โœ… ุงูˆู„ุง ุฏูˆุงุก betamethasone ูˆ dexamethasone ุงู‚ู„ mineralocorticoid activity ู…ู‚ุงุฑู†ุฉ ุจุจู‚ูŠู‡ ุงุฏูˆูŠุฉ corticosteroids ู„ุฐุง ุชุงุซูŠุฑ ุนู„ู‰ ุถุบุท ุงู„ุฏู… ุงู‚ู„
โœ…ุซุงู†ูŠุง ุงู„ benefit ู„ู‡ุฐู‡ ุงู„ุงุฏูˆูŠุฉ ููŠ ุงู„ุญุงู„ู‡ ุงู„ู…ุฐูƒูˆุฑู‡ ุจุชููˆู‚ risk
๐Ÿ›‘ Betamethasone and dexamethasone have low
mineralocorticoid activity compared with other corticosteroids; therefore, hypertension is not a contraindication to therapy๐Ÿ‘

#UpTodate2023
#remember
โœ…Elevated serum or plasma CRP is an independent predictor of atherosclerosis among apparently healthy men and women
โœ…. Among apparently healthy men, the plasma concentration of CRP predicts the long-term risk of a first myocardial infarction, ischemic stroke, hypertension, peripheral artery disease, sudden cardiac death, and total mortality
#UpTodate2023
Clinical Notes
#remember โœ…Elevated serum or plasma CRP is an independent predictor of atherosclerosis among apparently healthy men and women โœ…. Among apparently healthy men, the plasma concentration of CRP predicts the long-term risk of a first myocardial infarction, ischemicโ€ฆ
๐Ÿ›‘For patients at intermediate risk for ASCVD (ie, 10 to 20 percent risk at 10 years) who do not otherwise qualify for lipid-lowering therapy, we suggest a screening measurement of hs-CRP. We take the following approach to the interpretation of these values:
โœ…A value above 10 mg/L should prompt consideration of a source of infection or inflammation, with repeat measurement of hs-CRP in two weeks.
โœ…A value of 3 to 10 mg/L should prompt a discussion regarding overall ASCVD risk, lifestyle modifications, management of risk factors for atherosclerosis, and the possibility of risk reduction therapy using a statin.
โœ…A value of 1 to 3 mg/L should be repeated in two weeks to determine an average value and prompt a discussion regarding lifestyle modifications and the potential for treatment with a statin if the hs-CRP value is 2.0 mg/L or greater.
โœ…A value <1 mg/L suggests a lower risk of future ASCVD events.

#UpTodate2023
#salah
ููŠ ุฏุฑุงุณู‡ ููŠ ุงู…ุฑูŠูƒุง ุชู…ุช ุญูˆู„ ุงู„
Cardiovascular Health of Middle-Aged . Adults by Income Level
ู†ุณุจู‡ ุงู†ุชุดุงุฑ ุงู„ุถุบุท ูˆุงู„ุณูƒุฑ ูˆุงู„ุณู…ู†ู‡ ูˆุงุณุชุฎุฏุงู… ุงู„ุณุฌุงุฑุฉ ุนู†ุฏ ุงู„ุงุดุฎุงุต ุฐูˆูŠ ุงู„ุฏุญู„ ุงู„ู‚ู„ูŠู„ ู…ู‚ุงุฑู†ุฉ ุจุงู„ุฏุฎู„ ุงู„ุนุงู„ูŠ
ูˆุฌุฏ ุฃู† ุงู„ุฃุดุฎุงุต ุฐูˆูŠ ุงู„ุฏุฎู„ ุงู„ุงู‚ู„ ูƒุงู†ูˆุง ุงูƒุซุฑ ุนุฑุถุฉ ู„ุฃู…ุฑุงุถ ุงู„ุถุบุท ูˆุงู„ุณูƒุฑ ูˆุงุณุชุฎุฏุงู… ุงู„ุณุฌุงุฑู‡ ู…ู‚ุงุฑู†ุฉ ุจุงู„ุฃุดุฎุงุต ุฐูˆูŠ ุงู„ุฏุฎู„ ุงู„ุฃูƒุซุฑ
ุจูŠู†ู…ุง ุฐูˆูŠ ุงู„ุฏุฎู„ ุงู„ุนุงู„ูŠ ูƒุงู†ูˆุง ุงูƒุซุฑ ุนุฑุถู‡ ู„ุณูƒุฑ ูˆุงู„ุณู…ู†ู‡ ุงู„ู…ูุฑุทุฉ
#massoud
This media is not supported in your browser
VIEW IN TELEGRAM
ุฑุฌุงู„ ุงู„ู‚ุณุงู…๐Ÿ˜๐Ÿ˜
This media is not supported in your browser
VIEW IN TELEGRAM
ูˆุฌุนู„ู†ุง ู…ู† ุจูŠู† ุฃูŠุฏูŠู‡ู… ุณุฏุง ูˆู…ู† ุฎู„ูู‡ู… ุณุฏุง ูุฃุบุดูŠู†ุงู‡ู… ูู‡ู… ู„ุง ูŠุจุตุฑูˆู†
๐Ÿ›‘ูƒูŠู ูŠุชู… ู…ุนุงู„ุฌุฉ ู†ู‚ุต ููŠุชุงู…ูŠู† ุฏุงู„ ุŸ

โœ…ุญุณุจ ุชุฑูƒูŠุฒ serum 25(OH)D

๐Ÿ›‘ุงูˆู„ุง  ู„ูˆ ูƒุงู† serum 25(OH)D ุงู‚ู„ ู…ู† 12ng/ml
ุงูˆ ู…ุงูŠุณู…ู‰ ุจ Vitamin D deficiency)

ู‡ู†ุง ู†ุนุทูŠ ููŠ ุงู„ุบุงู„ุจ ู…ู† 25,000 ุฅู„ู‰  50,000 ูˆุญุฏู‡ ู…ู† ููŠุชุงู…ูŠู† D2 ุงูˆ D3 (cholecalciferol)  ุฃุณุจูˆุนูŠุง ู„ู…ุฏู‡ ุณุชู‡ ุฅู„ู‰ ุซู…ุงู†ูŠู‡ ุงุณุงุจูŠุน ุซู…  ู†ุนุทูŠ 800 ูˆุญุฏู‡ ูŠูˆู…ูŠุง ุŒู†ู‚ูŠู… ุงู„ู…ุนุงู„ุฌุฉ ุจุนุฏ ุซู„ุงุซู‡ ุฅู„ู‰ ุฃุฑุจุนุฉ ุฃุดู‡ุฑ ูˆู†ุณูˆูŠ ูุญุต ู„ุชุฑูƒูŠุฒ serum 25(OH)D


๐Ÿ›‘ุซุงู†ูŠุง ู„ูˆ ูƒุงู† ุชุฑูƒูŠุฒ  serum 25(OH)D ู…ุงุจูŠู† 12 ุฅู„ู‰ ุงู‚ู„ ู…ู† 20 ng/mL (ุงูˆ ู…ุงูŠุณู…ู‰ ุจ Vitamin D insufficiency)

ู‡ู†ุง ู†ุนุทูŠ ู…ู† 800 ุฅู„ู‰ 1000 ูˆุญุฏู‡ ูŠูˆู…ูŠุง
ู…ู…ูƒู† ู†ู‚ูŠู… ุงู„ู…ุนุงู„ุฌุฉ ุจุนุฏ 3 ุงุดู‡ุฑ
#UpTodate2023
#salah
#remember
๐Ÿ›‘about baclofen drugs

โœ…Gradual dose reduction is advised unless discontinuation is due to significant adverse effects or overdose-related emergencies;
โœ…chronic oral baclofen therapy should be discontinued slowly (eg, over at least 1 to 2 weeks or longer if withdrawal symptoms occur)
โŒ Abrupt discontinuation of oral or intrathecal baclofen may result in severe adverse effects, including multiple organ system failure and death
#UpTodate2023
ุฑุบู… ุงู„ุฏู…ุงุฑ ุงู„ูƒุจูŠุฑ ููŠ ู‚ุทุงุน ุบุฒ ุฉ ุ›ุงุชูˆู‚ุน ุจุฃู†ู‡ ู‚ุฑูŠุจุง ุณูŠูƒูˆู† ู‡ู†ุงูƒ ุณูŠู†ุงุฑูŠูˆ ุงุฎุฑ ูŠุดุงุจู‡ ุณูŠู†ุงุฑูŠูˆ ุงู„ุณุงุจุน ู…ู† ุฃูƒุชูˆุจุฑ ุงู„ู…ุฌูŠุฏ ูˆู‡ุฐู‡ ุงู„ู…ุฑุฉ ู„ูŠุณ ุบู„ุงู ุบุฒุฉ ูˆุฅู†ู…ุง ูˆุณุท ุชู„ ุฃุจูŠุจุŒ ๐ŸŒš ูˆู„ูŠุณ ู…ู† ุงู„ุฌูˆ ูˆุฅู†ู…ุง ุนุจุฑ ุงู†ูุงู‚๐ŸŒš ูƒูŠู ู…ุฏุฑูŠ ุจุณ ุงุญุณ ุงู„ู…ู‚ุง ูˆู…ุฉ ู…ุฎุจูŠ ุดูŠ ูƒุจูŠุฑ ุŒูˆุฌู…ุนุฉ ู…ุจุงุฑูƒุฉ ุนู„ูŠูƒู…
๐Ÿ›‘ุงุณุชุฎุฏุงู…ุงุช ุฏูˆุงุก colchicine ููŠ ู…ุฑุถู‰ ุงู„ู‚ู„ุจ ูƒุงู„ุงุชูŠ
โœ…ู„ุฏูˆุงุก colchicine ุงุณุชุฎุฏุงู…ุงุช ุนุฏูŠุฏู‡ ููŠ ู…ุฑุถู‰ ุงู„ู‚ู„ุจ ู†ุฐูƒุฑู‡ุง ุจุงุฎุชุตุงุฑ

โœ…ุงูˆู„ุง ููŠ ุญุงู„ู‡ ุงู„ุชู‡ุงุจ ุงู„ุชุฃู…ูˆุฑ pericardial disease
โœ…ููŠ ุญุงู„ู‡ acute and recurrent pericarditis ูŠูˆุตู‰ ุงู„ุฌุงูŠุฏู„ุงูŠู† ุงู„ุงูˆุฑูˆุจูŠ ESC ุจุงุณุชุฎุฏุงู… ุฏูˆุงุก colchicine ุฎูŠุงุฑ ุงูˆู„ ุจูŠู†ู…ุง ุงู„ุฌุงูŠุฏู„ุงูŠู† ุงู„ุฃู…ุฑูŠูƒูŠ ูŠูˆุตู‰ ุจุงุณุชุฎุฏุงู… ุฏูˆุงุก colchicine ููŠ ุญุงู„ู‡ ูƒุงู† pericarditis ุจุนุฏ MI
โœ…ุงู„ุฌุฑุนู‡ ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุชูŠู† ุญุณุจ ุงู„ูˆุฒู† ู„ูˆ ูƒุงู† ูˆุฒู† ุงู„ู…ุฑูŠุถ ุงู‚ู„ ู…ู† 70 ูƒูŠู„ูˆ ูŠุงุฎุฐ 0.5mg ู…ุฑู‡ ููŠ ุงู„ูŠูˆู… ู„ูˆ ูˆุฒู†ู‡ ุงูƒุซุฑ ู…ู† 70 ูŠุงุฎุฐ ู†ูุณ ุงู„ุฌุฑุนู‡ ูˆู„ูƒู† ู…ุฑุชูŠู† ููŠ ุงู„ูŠูˆู… ู„ู…ุฏู‡ ุซู„ุงุซู‡ ุฃุดู‡ุฑ
โœ…ู…ู…ูƒู† ููŠ ุญุงู„ู‡
๐Ÿ›‘Post-Pericardiotomy Syndrome pericarditis
๐Ÿ›‘Dressler's syndrome pericarditis
ู„ู…ุฏู‡ ุดู‡ุฑ ุจู†ูุณ ุงู„ุฌุฑุนู‡ ุงู„ู…ุฐูƒูˆุฑู‡

๐Ÿ›‘ุซุงู†ูŠุง ููŠ ุญุงู„ู‡ ACS ุงูˆ chronic coronary syndrome
โœ…ู…ุชู‰ ุจุถุจุทุŸ
ุฐูƒุฑุชู‡ ููŠ ู…ู†ุดูˆุฑ ุณุงุจู‚ ุ›ู„ู…ู†ุน Secondary attack ููŠ ุญุงู„ู‡ ุถุจุทู†ุง ุฌู…ูŠุน risk factors ู„ ACs ู…ุซู„ dyslipidemia ูˆ hypertension ูˆ DM ..ุงู„ุฎ
ู‡ู†ุง ู…ู…ูƒู† ู†ุนุทูŠ 0.5mg ููŠ ุงู„ูŠูˆู… ู‚ุฏ ู†ุณุชู…ุฑ ุจู‡ ู…ุฏู‰ ุงู„ุญูŠุงุฉ

๐Ÿ›‘ุงุฎูŠุฑุง ู‡ู†ุงูƒ ุงุณุชุฎุฏุงู… ุบูŠุฑ ู…ุดู‡ูˆุฑ ูˆู„ูƒู† ู‚ุฏ ู†ุณุชุฎุฏู…ู‡ ู„ู…ู†ุน atrial fibrillation ุจุนุฏ ุงู„ุนู…ู„ูŠุงุช ุงู„ุฌุฑุงุญูŠุฉ ุงูˆ Post-ablation atrial fibrillation ุจุฌุฑุนู‡ 0.5mg ู…ุฑู‡ ุฅู„ู‰ ู…ุฑุชูŠู† ููŠ ุงู„ูŠูˆู… ู„ู…ุฏู‡ ุดู‡ุฑ ุฅู„ู‰ ุดู‡ุฑูŠู†

#tips_and_tricks_in_cardiology
#Salah
Clinical Notes
๐Ÿ›‘ุงุณุชุฎุฏุงู…ุงุช ุฏูˆุงุก colchicine ููŠ ู…ุฑุถู‰ ุงู„ู‚ู„ุจ ูƒุงู„ุงุชูŠ โœ…ู„ุฏูˆุงุก colchicine ุงุณุชุฎุฏุงู…ุงุช ุนุฏูŠุฏู‡ ููŠ ู…ุฑุถู‰ ุงู„ู‚ู„ุจ ู†ุฐูƒุฑู‡ุง ุจุงุฎุชุตุงุฑ โœ…ุงูˆู„ุง ููŠ ุญุงู„ู‡ ุงู„ุชู‡ุงุจ ุงู„ุชุฃู…ูˆุฑ pericardial disease โœ…ููŠ ุญุงู„ู‡ acute and recurrent pericarditis ูŠูˆุตู‰ ุงู„ุฌุงูŠุฏู„ุงูŠู† ุงู„ุงูˆุฑูˆุจูŠ ESC ุจุงุณุชุฎุฏุงู… ุฏูˆุงุก colchicineโ€ฆ
ููŠ ุญุงู„ู‡ ACs ุฐูƒุฑุชู‡ ุจุชูุตูŠู„ ู‚ุจู„ ูุชุฑู‡

ู…ุงุฐุง ุนู† ุฏูˆุฑ ุฏูˆุงุก colchicine ููŠ ุงู…ุฑุงุถ CVD
ููŠ ุงู„ุฌุงูŠุฏู„ุงูŠู† ุงู„ุฌุฏูŠุฏู‡ ESC 2021

ุชูƒู„ู…ูˆุง ุนู†  ุญุงุฌู‡ ุฌุฏูŠุฏู‡ ุงุณู…ู‡ุง

Residual risk factors
ูˆู‡ู… ุซู„ุงุซู‡

ู…ู† ุถู…ู†ู‡ุง
Residual inflammatory  risk

ุจุงู„ู…ุฎุชุตุฑ ูƒุงู† ููŠ ู…ุฑุถู‰ ACs ูŠูƒูˆู†ูˆุง ู…ุถุจุทูŠู† ูƒู„ risk factors
ู…ุซู„ diabetes ูˆ Hypertension ูˆ atherosclerosis
ุนุดุงู† ู…ุงูŠุฏุฎู„ูˆุง ู†ูˆุจู‡ ุซุงู†ูŠู‡ ู…ู† ischmic
ูˆู…ู„ุชุฒู…ูŠู† ุจุงู„ุนู„ุงุฌ ูˆ optimal dose

ูˆู…ุน ู‡ุฐุง ูƒุงู†ูˆุง ูŠุฏุฎู„ูˆุง ููŠ ู†ูˆุจุงุช ุซุงู†ูŠู‡๐Ÿ™๐Ÿ˜

ูู‡ู… ุจุญุซูˆุง  ุนู† ุงุณุจุงุจ

ูˆู„ู‚ูˆุง ู…ุซู„ุง ุงู† inflammation mediator ู…ุฑุชูุนู‡
ูˆุงู†  CRP ูƒุงู† ู…ุฑุชูุน ู‚ูˆูŠ

ููŠ ู‡ุฐู‡ ุงู„ูุฆู‡ ู…ู† ุงู„ู…ุฑุถู‰ ุจูŠูƒูˆู† colchicine ู…ููŠุฏ๐Ÿ‘

#Salah
ู†ุจุงุฑูƒ ู„ู„ุฒู…ู„ุงุก ููŠ ุฌุงู…ุนู‡ 21 ุณุจุชู…ุจุฑ ุงู„ุฏูุนู‡ ุงู„ุฃูˆู„ู‰ ุทุจ ุจุดุฑูŠ ุฅู†ู‡ุงุก ู…ุฑุญู„ู‡ ุงู„ุจูƒุงู„ูˆุฑูŠูˆุณ
ุงู„ุฏูุนู‡ ุงู„ุนุธูŠู…ุฉ ุงู„ุฐูŠ ู„ุทุงู„ู…ุง ุชู…ู†ูŠุช ุฃู† ุฃูƒูˆู† ูˆุงุญุฏ ู…ู†ู‡ู… ู„ู…ุง ุฑุฃูŠุชู‡ ู…ู† ุชุนุงูˆู† ูˆุชุงูƒุชู ุจูŠู†ู‡ู… ูˆุชุญุฏูŠู‡ู… ู„ูƒุซูŠุฑ ู…ู† ุงู„ุตุนุงุจ ุŒ ูˆุญุจู‡ู… ู„ุชุฎุตุตู‡ู… ุงู„ุดุบู ูŠุงุฌู…ุงุนู‡ ุงู„ุฐูŠ ูŠู…ุชู„ูƒูˆู†ู‡ ู„ุงูŠูˆุฌุฏ ู„ุฏู‰ ุทู„ุงุจ ุขุฎุฑูŠู†ุŒูˆุงุซู‚ ูƒู„ ุงู„ุซู‚ู‡ ุจุฃู†ู‡ ู‡ุฐู‡ ุงู„ุฏูุนู‡ ุจูŠูƒูˆู† ู„ู‡ู… ู…ูƒุงู†ุฉ ูƒุจูŠุฑุฉ ููŠ ุงู„ู…ุณุชู‚ุจู„

ุจุงู„ุนุงู…ูŠุฉ ูƒุฐุง ุงุบู„ุจู‡ู… ุนุจุงู‚ุฑุฉ ูˆุฏูˆุงููŠุฑ๐Ÿ˜
2024/09/30 05:17:48
Back to Top
HTML Embed Code: